Transgenic tobacco expressed HPV16-L1 and LT-B combined immunization induces strong mucosal and systemic immune responses in mice

Human Vaccines and Immunotherapeutics

Volumn 9, Issue 1, 2013, Pages 83-89

  Liu, Hongli ^a   Li, Xukui ^a   Lei, Ting ^a   Li, Wensheng ^a   Si, Lusheng ^a   Zheng, Jin ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

HPV16L1; LT B; Mucosal immunity; Systemic immunity; Transgenic tobacco plants

Indexed keywords

ESCHERICHIA COLI ENTEROTOXIN; ESCHERICHIA COLI HEAT LABILE ENTEROTOXIN; GAMMA INTERFERON; GANGLIOSIDE GM1; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INTERLEUKIN 4; UNCLASSIFIED DRUG; WART VIRUS VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING ASSAY; CD4+ T LYMPHOCYTE; CELL STIMULATION; CONTROLLED STUDY; DRUG POTENCY; ELECTRON MICROSCOPY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HEMAGGLUTINATION INHIBITION; HUMAN PAPILLOMAVIRUS TYPE 16; IMMUNITY; IMMUNIZATION; IMMUNOGENICITY; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOPHARMACOLOGY; INTESTINE INJURY; LYMPHOCYTE PROLIFERATION; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; PAPILLOMAVIRUS INFECTION; PLANT LEAF; PROTEIN EXPRESSION; SPLEEN CELL; SYSTEMIC IMMUNITY; TOBACCO; TRANSGENIC PLANT; UTERINE CERVIX CANCER;

HPV16L1; LT-B; MUCOSAL IMMUNITY; SYSTEMIC IMMUNITY; TRANSGENIC TOBACCO PLANTS;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, ORAL; ANIMALS; ANTIBODIES, VIRAL; BACTERIAL TOXINS; CAPSID PROTEINS; CELL PROLIFERATION; ENTEROTOXINS; ESCHERICHIA COLI PROTEINS; FEMALE; FLOW CYTOMETRY; IMMUNITY, MUCOSAL; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INTERFERON-GAMMA; LEUKOCYTES, MONONUCLEAR; MICE; MICE, INBRED BALB C; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS VACCINES; PLANTS, GENETICALLY MODIFIED; RECOMBINANT PROTEINS; SPLEEN; TOBACCO; VACCINATION;

EID: 84874708451     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.4161/hv.22292     Document Type: Article

References (32)

1. McCance DJ. Human papillomaviruses and cervical cancer. J Med Microbiol 1998; 47:371-3; PMID:9879936; http://dx.doi.org/10.1099/00222615-47-5-371.
2. Zhou J, Sun XY, Stenzel DJ, Frazer IH. Expression of vaccinia recombinant HPV 16 L1 and L2 ORF proteins in epithelial cells is sufficient for assembly of HPV virion-like particles. Virology 1991; 185:251-7; PMID:1656586; http://dx.doi.org/10.1016/0042-6822(91)90772-4.
3. Revaz V, Benyacoub J, Kast WM, Schiller JT, De Grandi P, Nardelli-Haefliger D. Mucosal vaccination with a recombinant Salmonella typhimurium expressing human papillomavirus type 16 (HPV16) L1 virus-like particles (VLPs) or HPV16 VLPs purified from insect cells inhibits the growth of HPV16-expressing tumor cells in mice. Virology 2001; 279:354-60; PMID:11145916; http://dx.doi.org/10.1006/viro.2000.0717.
4. Osen W, Jochmus I, Müller M, Gissmann L. Immunization against human papillomavirus infection and associated neoplasia. J Clin Virol 2000; 19:75-8; PMID:11091150; http://dx.doi.org/10.1016/S1386-6532(00)00090-1.
5. Paz De la Rosa G, Monroy-García A, Mora-García MdeL, Peña CG, Hernández-Montes J, Weiss-Steider B, et al. An HPV 16 L1-based chimeric human papilloma virus-like particles containing a string of epitopes produced in plants is able to elicit humoral and cytotoxic T-cell activity in mice. Virol J 2009; 6:2-13; PMID:19126233; http://dx.doi.org/10. 1186/1743-422X-6-2.
6. De Vuyst H, Clifford GM, Nascimento MC, Madeleine MM, Franceschi S. Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis. Int J Cancer 2009; 124:1626-36; PMID:19115209; http://dx.doi.org/10.1002/ijc.24116.
7. Kohl TO, Hitzeroth II, Christensen ND, Rybicki EP. Expression of HPV-11 L1 protein in transgenic Arabidopsis thaliana and Nicotiana tabacum. BMC Biotechnol 2007; 7:56-70; PMID:17850660; http://dx.doi.org/10.1186/1472-6750-7- 56.
8. de Haan L, Hirst TR. Cholera toxin and related enterotoxins: a cell biological and immunological perspective. J Nat Toxins 2000; 9:281-97; PMID:10994530.
9. Richards CM, Aman AT, Hirst TR, Hill TJ, Williams NA. Protective mucosal immunity to ocular herpes simplex virus type 1 infection in mice by using Escherichia coli heat-labile enterotoxin B subunit as an adjuvant. J Virol 2001; 75:1664-71; PMID:11160664; http://dx.doi.org/10.1128/JVI.75.4.1664-1671.2001.
10. Williams NA, Hirst TR, Nashar TO. Immune modulation by the cholera-like enterotoxins: from adjuvant to therapeutic. Immunol Today 1999; 20:95-101; PMID:10098329; http://dx.doi.org/10.1016/S0167-5699(98)01397-8.
11. Wang J, Li L, Zheng J, Yu J, Yang X, Geng YP, et al. Highly efficient expression, purification of recombinant LTB protein and its activity against mucosal immunoadjuvant by nasal immunization. Chin Med J (Engl) 2003; 116:1115-7; PMID:12890398.
12. Norton EB, Lawson LB, Freytag LC, Clements JD. Characterization of a mutant Escherichia coli heatlabile toxin, LT(R192G/L211A), as a safe and effective oral adjuvant. Clin Vaccine Immunol 2011; 18:546-51; PMID:21288994; http://dx.doi.org/10.1128/CVI.00538-10.
13. da Hora VP, Conceição FR, Dellagostin OA, Doolan DL. Non-toxic derivatives of LT as potent adjuvants. Vaccine 2011; 29:1538-44; PMID:21163247; http://dx.doi.org/10.1016/j.vaccine.2010.11.091.
14. Zhao L, Hao D, Chen L, Lu Q, Zhang Y, Li Y, et al. Roles for a soybean RAV-like orthologue in shoot regeneration and photoperiodicity inferred from transgenic plants. J Exp Bot 2012; 63:3257-70; PMID:22389516; http://dx.doi.org/10.1093/jxb/ers056.
15. Bahariah B, Parveez GK, Masani MY, Khalid N. Construction of phosphomannose isomerase (PMI) transformation vectors and evaluation of the effectiveness of vectors in tobacco (Nicotiana tabacum L). Bioinformation 2012; 8:151-7; PMID:22368388; http://dx.doi.org/10.6026/97320630008151.
16. Zheng J, Yang X, Sun Y, Lai B, Wang Y. Stable highlevel expression of truncated human papillomavirus type 16 L1 protein in Drosophila Schneider-2 cells. Acta Biochim Biophys Sin (Shanghai) 2008; 40:437-42; PMID:18465029; http://dx.doi.org/10.1111/j.1745-7270.2008.00417.x.
17. Waheed MT, Gottschamel J, Hassan SW, Lössl AG. Plant-derived vaccines: An approach for affordable vaccines against cervical cancer. Hum Vaccin Immunother 2012; 8:8; PMID:22327500.
18. Ma JK. Genes, greens, and vaccines. Nat Biotechnol 2000; 18:1141-2; PMID:11062427; http://dx.doi.org/10.1038/81113.
19. Tiwari S, Verma PC, Singh PK, Tuli R. Plants as bioreactors for the production of vaccine antigens. Biotechnol Adv 2009; 27:449-67; PMID:19356740; http://dx.doi.org/10.1016/j.biotechadv.2009.03.006.
20. Lowy DR, Kirnbauer R, Schiller JT. Genital human papillomavirus infection. Proc Natl Acad Sci USA 1994; 91:2436-40; PMID:8146136; http://dx.doi.org/10.1073/pnas.91.7.2436.
21. Breitburd F, Coursaget P. Human papillomavirus vaccines. Semin Cancer Biol 1999; 9:431-44; PMID:10712890; http://dx.doi.org/10.1006/scbi.1999.0147.
22. Holmgren J, Czerkinsky C, Eriksson K, Mharandi A. Mucosal immunisation and adjuvants: a brief overview of recent advances and challenges. Vaccine 2003; 21(Suppl 2):S89-95; PMID:12763689; http://dx.doi.org/10.1016/S0264-410X(03) 00206-8.
23. Plant A, Williams R, Jackson ME, Williams NA. The B subunit of Escherichia coli heat labile enterotoxin abrogates oral tolerance, promoting predominantly Th2-type immune responses. Eur J Immunol 2003; 33:3186-95; PMID:14579287; http://dx.doi.org/10.1002/eji.200324154.
24. Streatfield SJ, Howard JA. Plant production systems for vaccines. Expert Rev Vaccines 2003; 2:763-75; PMID:14711360; http://dx.doi.org/10.1586/14760584. 2.6.763.
25. Liu HL, Li WS, Lei T, Zheng J, Zhang Z, Yan XF, et al. Expression of human papillomavirus type 16 L1 protein in transgenic tobacco plants. Acta Biochim Biophys Sin (Shanghai) 2005; 37:153-8; PMID:15756416.
26. Buck CB, Pastrana DV, Lowy DR, Schiller JT. Generation of HPV pseudovirions using transfection and their use in neutralization assays. Methods Mol Med 2005; 119:445-62; PMID:16350417.
27. Maclean J, Koekemoer M, Olivier AJ, Stewart D, Hitzeroth II, Rademacher T, et al. Optimization of human papillomavirus type 16 (HPV-16) L1 expression in plants: comparison of the suitability of different HPV-16 L1 gene variants and different cell-compartment localization. J Gen Virol 2007; 88:1460-9; PMID:17412974; http://dx.doi.org/10.1099/vir.0.82718-0.
28. Zagouras P, Rose JK. Carboxy-terminal SEKDEL sequences retard but do not retain two secretory proteins in the endoplasmic reticulum. J Cell Biol 1989; 109:2633-40; PMID:2592401; http://dx.doi.org/10.1083/jcb.109.6.2633.
29. Liu HL, Zhang Z, Li WS, Zheng J, Kong LH, Wang Y, Si LS. Expression of E. coli heat-lablie enterotoxin B subunit in transgenic tobacco plants. Journal of medical colleges of PLA 2005; 20:262-7.
30. Yili W, Lusheng S. Expression of recombinant LTB protein in Marine vibrio VSP60. Methods Mol Biol 2005; 308:43-9; PMID:16082024.
31. Lauterslager TG, Florack DE, van der Wal TJ, Molthoff JW, Langeveld JP, Bosch D, et al. Oral immunisation of naive and primed animals with transgenic potato tubers expressing LT-B. Vaccine 2001; 19:2749-55; PMID:11257419; http://dx.doi.org/10.1016/S0264-410X(00)00513-2.
32. Zheng J, Ma J, Yang XF, Liu HL, Cheng HW, Si LS, et al. Highly efficient and economical baculovirus expression system for preparing human papillomavirus type16 virus-like particle. Acta Biochim Biophys Sin (Shanghai) 2004; 36:548-52; PMID:15295647; http://dx.doi.org/10.1093/abbs/36.8.548.